|

Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy

RECRUITINGN/ASponsored by Taipei Veterans General Hospital, Taiwan
Actively Recruiting
PhaseN/A
SponsorTaipei Veterans General Hospital, Taiwan
Started2024-08-01
Est. completion2028-08-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06461780

Summary

During the immune checkpoint inhibitor therapy (ICIT), most of the patients stay at home, but there is lacking of the studies to explore their physical and psychological distress, financial toxicity, care needs, and quality of life. Therefore, the aims of this program are to (1) explore the immune-related adverse event (irAE) severity, distress, financial toxicity, and quality of life and examine the psychometric testing of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM); (2) establish the LINE group for assessing irAE severity and change trajectory of quality of life in one-year follow-up and (3) combined retrospective chart review and the finding in aim (2) to develop the risk prediction model in order to identify the high risk population.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* (1) Patients diagnose cancer and are informed
* (2) Aged ≥18 years old
* (3) Conscious clear and able to communicate

Exclusion Criteria:

* (1) Patients who are under other clinical trial

Conditions7

CancerCare NeedDistress, EmotionalFinancial ToxicityImmunotherapyIrAEQuality of Life

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.